Research Article
Effect of Moxibustion on β-EP and Dyn Levels of Pain-Related Indicators in Patients with Rheumatoid Arthritis
Table 1
Baseline characteristics.
| | Outcome measures | Treatment group (n = 30) | Control group (n = 31) | value |
| | Characteristic | | Gender, male/female | 4/26 | 5/26 | 0.758 | | Age (y), mean (SD) | 53.00 (8.80) | 49.39 (7.72) | 0.093# | | Disease duration (y), mean (SD) | 10.11 (9.02) | 9.13 (9.07) | 0.677# |
| | Clinical symptoms | | VAS score, mean (SD) | 6.47 (1.53) | 6.10 (1.76) | 0.38# | | Morning stiffness score, mean (SD) | 2.47 (2.01) | 2.58 (1.80) | 0.82# | | DAS28 score, mean (SD) | 5.33 (0.99) | 5.50 (1.02) | 0.49# |
| | Routine inspection indexes | | RF (IU/ml), mean (SD) | 209.60 (249.12) | 190.95 (210.32) | 0.75▲ | | ESR (mm/60 min), mean (SD) | 65.40 (34.90) | 64.61 (33.77) | 0.93▲ | | CRP (mg/L), mean (SD) | 20.21 (22.99) | 18.01 (21.20) | 0.70▲ |
|
|
value by χ2 test. # value by independent samples t-test. ▲ value by Mann–Whitney U test. |
